Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
102.347,20
1,32%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Astria Therapeutics Inc (ATXS) Astria Therapeutics Inc (ATXS) Notizie

Astria Therapeutics Inc

ATXS
7,50
-0,25 (-3,23%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/1/202514:09EDGAR2Form 8-K - Current report
13/1/202514:00BWAstria Therapeutics Announces Design of ALPHA-ORBIT Pivotal..
07/1/202513:45EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
03/1/202522:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
19/12/202422:05EDGAR2Form 8-K - Current report
11/12/202414:00BWAstria Therapeutics Announces Positive Final Results from..
03/12/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
14/11/202423:45EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202418:03EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:21EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:10BWAstria Therapeutics Reports Third Quarter 2024 Financial..
13/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202414:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
08/11/202420:17EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/10/202413:00BWAstria Therapeutics to Present at Upcoming Canadian Society..
21/10/202414:00BWAstria Therapeutics to Present at Upcoming American College..
16/10/202414:00BWEuropean Commission Grants Orphan Medicinal Product..
02/10/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/9/202414:00BWAstria Therapeutics Receives FDA Orphan Drug Designation for..
27/9/202414:00BWAstria Therapeutics to Present at Upcoming Global Angioedema..
19/9/202414:00BWAstria Therapeutics to Present at Upcoming European Academy..
04/9/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/8/202414:00BWAstria Therapeutics to Present at Upcoming Bradykinin..
29/8/202414:00BWAstria Therapeutics to Participate in Upcoming Morgan..
12/8/202422:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202422:10BWAstria Therapeutics Reports Second Quarter 2024 Financial..
12/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:00BWAstria Therapeutics Chooses Ypsomed’s YpsoMate as the..
07/8/202414:00BWAstria Therapeutics to Participate in Upcoming 2024 Wedbush..
02/8/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
02/7/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
06/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:05EDGAR2Form 8-K - Current report
04/6/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/5/202414:00BWAstria Therapeutics to Present at Upcoming Jefferies..
24/5/202414:00BWAstria Therapeutics to Present at Upcoming Eastern Allergy..
23/5/202414:00BWAstria Therapeutics to Present at Upcoming European Academy..
09/5/202422:10BWAstria Therapeutics Reports First Quarter 2024 Financial..
09/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:00BWAstria Therapeutics to Present at Upcoming Society for..
02/5/202422:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
09/4/202414:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
03/4/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
25/3/202412:30BWAstria Therapeutics Announces Positive Initial..
05/3/202422:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
Apertura: 7,85 Min: 7,45 Max: 7,90
Chiusura: 7,75

La tua Cronologia

NASDAQ
ATXS
Astria Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network